Aripiprazole is associated with early onset of Tardive Dyskinesia like presentation in a patient with ABI and psychosis

Purpose: This report describes the early onset Tardive Dyskinesia like presentation during treatment with Aripiprazole. Case study: The patient, who had a history of acquired brain injury, was receiving treatment for his psychotic illness characterized by persecutory delusions, second person auditor...

Full description

Saved in:
Bibliographic Details
Published in:Brain injury 2008, Vol.22 (1), p.99-102
Main Authors: Zaidi, Syed Habib Haider, Faruqui, Rafey A.
Format: Article
Language:English
Subjects:
acquired brain injury (ABI)
Adult
Antipsychotic Agents - adverse effects
Aripiprazole
Brain Injuries - psychology
Dyskinesia, Drug-Induced - etiology
Humans
Male
Piperazines - adverse effects
Psychotic Disorders - complications
Psychotic Disorders - drug therapy
Quinolones - adverse effects
side-effects
Tardive Dyskinesia
treatment of psychosis
Treatment Outcome
Withholding Treatment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: This report describes the early onset Tardive Dyskinesia like presentation during treatment with Aripiprazole. Case study: The patient, who had a history of acquired brain injury, was receiving treatment for his psychotic illness characterized by persecutory delusions, second person auditory hallucinations, self-neglect and challenging behaviours. Tardive Dyskinesia is not a well reported side-effect of Aripiprazole. Conclusions: This report demonstrates onset of this side-effect upon commencement of Aripiprazole and cessation of this side-effect upon termination of this medication. This case report highlights the need for careful monitoring of neurological side-effects in patients with acquired brain injury requiring treatment with anti-psychotic medication.
ISSN:0269-9052
1362-301X
DOI:10.1080/02699050701822493